Navigation Links
Terumo Interventional Systems Launches a Complete Line of Coronary Diagnostic Catheters
Date:12/1/2008

SOMERSET, N.J., Dec. 1 /PRNewswire/ -- The Tiger and Jacky tip shapes stand out in Terumo's newest family of products.

Terumo Interventional Systems announces the launch of Optitorque(TM), its new line of coronary diagnostic catheters, featuring the exclusive Tiger and Jacky tip shapes designed and cleared specifically for transradial procedures.

"The Optitorque catheters, specially designed for radial approach, will help to generalize the radial technique by reducing the learning curve," said Dr. Ramon Quesada, Medical Director of Interventional Cardiology at Miami Baptist Cardiac & Vascular Institute.

With a simple clockwise or counter clockwise rotation, the Tiger and Jacky tip shapes enable angiography of both the RCA and LCA with one catheter. This eliminates the catheter exchange step and can potentially shorten procedure and fluoroscopic time.

"These Optitorque catheters are valuable tools for the transradial approach. They can be used for left coronary artery, right coronary artery and LV. So, the need for the exchange of catheters is greatly reduced ... They are great tools and make radial cardiac catheterization easier," said Tak Kwan, MD, FACC Associate Clinical Professor of Medicine, Senior Associate Director of Cardiac Catheterization Laboratory and Interventional Cardiology Beth Israel Medical Center.

"The Tiger and Jacky tip shapes are paramount to the Optitorque product line. The Optitorque family offers optimum torque control and precise placement, which contribute to catheterization success," said Gary Clifton, Marketing Manager for Terumo Interventional System's coronary product line. "It is the coronary diagnostic catheter to use when performance matters."

With its double-braided stainless steel mesh middle layer for superior (1:1) torque control and its large lumen for high flow of contrast, the Optitorque's construction is the key to its performance.

For more information, customers can contact Terumo Interventional Systems by calling its Inside Sales Customer Care Team at 800-862-4143 or by visiting www.terumois.com.

Terumo Interventional Systems

Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical Corporation, directly markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolization products for use in a multitude of different interventional procedures.

Interventional Radiologists, Interventional Neuroradiologists, Interventional Cardiologists and Vascular Surgeons are among the medical professionals who depend upon TIS products to access and cross difficult-to-reach lesions thereby allowing therapeutic intervention in previously unreachable vascular beds.

Terumo Medical Corporation

Founded in 1972 as a Terumo Corporation subsidiary, Terumo Medical Corporation (TMC) develops, manufactures and markets high-quality medical devices used in a broad range of applications in numerous healthcare markets. TMC manufactures a broad portfolio of entry-site management products, IV catheters and syringes, and a line of sterile connection devices used in hospitals and blood banks worldwide.

Terumo Corporation

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with $3.0 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the healthcare market and by responding to the needs of healthcare providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543:JP) and is a component of the Nikkei 225, Japan's leading stock index.


'/>"/>
SOURCE Terumo Interventional Systems
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Affiliates
2. Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President
3. Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007
4. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
5. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
6. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
7. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
8. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. NxStage Medical Provides Update on Medisystems Acquisition
11. ICx Awarded $1.5 M Contract by Department of Homeland Security for Development of Next Generation Bio Aerosol Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... -- Bioptix, Inc. (Nasdaq: BIOP ... 14, 2017 the Board of Directors of the Company ... certain employees associated with the September 2016 acquisition of ... on January 16, 2017 and terminations are expected to ... severance benefits in certain circumstances of up to one ...
(Date:1/20/2017)... 2017 Stock-Callers.com explores the Biotech ... the most recent performances of select equities. In this ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ABEO ... and Sage Therapeutics Inc. (NASDAQ: SAGE ). ... Research, global Biotech market size is expected to reach $604.40 billion by 2020 ...
(Date:1/19/2017)... Research and Markets has announced the addition of the ... - Global Opportunity Analysis and Industry Forecast, 2014-2022" report to ... ... to reach $15,737 million by 2022 from $6,521 in 2015, growing ... Omic technologies segment accounted for more than half of the ...
(Date:1/19/2017)... Research and Markets ... has announced the addition of the ... 2025" report to their offering. Report ... provides a detailed analysis on current and future market trends to identify ... market values as the base numbers Key market trends ...
Breaking Biology Technology:
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/12/2017)... 2017 A new report by Allied Market Research, titled, "Global ... technology market is expected to generate revenue of $10.72 billion by 2022, with an ... Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) In the year ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
Breaking Biology News(10 mins):